Alkermes plc. (ALKS): Total Liabilities
$667.70M
As of 2025-12-31
$2.58B
As of 2026-06-30
-10.1%
3-year compound annual growth
-5.4%
5-year compound annual growth
+2.1%
10-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $667.70M | +13.1% | 2026-02-25, Balance as of period end |
| 2024-12-31 | $590.59M | -36.7% | 2026-02-25, Balance as of period end |
| 2023-12-31 | $933.54M | +1.4% | 2025-02-12, Balance as of period end |
| 2022-12-31 | $920.23M | +0.9% | 2024-02-21, Balance as of period end |
| 2021-12-31 | $911.90M | +3.3% | 2023-02-16, Balance as of period end |
| 2020-12-31 | $882.75M | +22.6% | 2022-02-16, Balance as of period end |
| 2019-12-31 | $719.96M | +10.1% | 2021-02-11, Balance as of period end |
| 2018-12-31 | $653.72M | +10.0% | 2020-02-13, Balance as of period end |
| 2017-12-31 | $594.42M | +15.0% | 2019-02-15, Balance as of period end |
| 2016-12-31 | $516.94M | -4.5% | 2018-02-16, Balance as of period end |
| 2015-12-31 | $541.47M | +3.7% | 2017-02-17, Balance as of period end |
| 2014-12-31 | $522.22M | +1.9% | 2016-02-25, Balance as of period end |
| 2013-12-31 | $512.40M | n/a | 2015-02-24, Balance as of period end |
| 2013-03-31 | $517.92M | -10.9% | 2013-05-23, Balance as of period end |
| 2012-03-31 | $581.37M | +862.0% | 2013-05-23, Balance as of period end |
| 2011-03-31 | $60.43M | n/a | 2012-05-18, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Alkermes plc. (ALKS) | 2025-12-31 | $667.70M | +13.1% |
| Phibro Animal Health Corp (PAHC) | 2026-06-30 | $1.12B | +3.8% |
| PTC Therapeutics, Inc. (PTCT) | 2025-12-31 | $3.10B | +10.7% |
| Indivior Pharmaceuticals, Inc. (INDV) | 2025-12-31 | $1.30B | -21.3% |
| Prestige Consumer Healthcare Inc. (PBH) | 2026-03-31 | $1.61B | +2.5% |
| Acadia Pharmaceuticals Inc (ACAD) | 2025-12-31 | $336.81M | -26.0% |
| Sarepta Therapeutics, Inc. (SRPT) | 2025-12-31 | $2.21B | -9.3% |
| Madrigal Pharmaceuticals, Inc. (MDGL) | 2025-12-31 | $656.90M | +128.2% |
| Ionis Pharmaceuticals Inc (IONS) | 2025-12-31 | $3.03B | +25.6% |
Compare ALKS, PAHC, PTCT, INDV side by side · Screen every company in Pharmaceutical Preparations ↗